Dr Gourgari received her medical degree in Aristotle University, Greece. She completed her training in Pediatrics at Miami Childrens Hospital and joined the Pediatric Endocrinology Division of National Institute of Child Health and Human Development in July 2010.
As a pediatric fellow at National Institute of Child Health and Human Development Dr Gourgari has the opportunity to gain clinical expertise in the management of rare disorders, such as congenital adrenal hyperplasia. Patients with congenital adrenal hyperplasia come to NIH from all over the country to receive recommendations for treatment. These patients can have extremely short stature, osteoporosis, hypertension and infertility as a result of inappropriate management. Moreover, they are at risk for life threatening episodes. Furthermore, Dr Gourgari treats pediatric patients with large cell calcifying Sertoli cell tumors of the testicles that are referred to NIH from all over the country. Also, Dr Gourgari treats pediatric patients with other rare endocrine diseases such as gigantism, McCune Albright syndrome, insulin receptor mutations, lipodystrophy and pheochromocytomas.
Dr Gourgari is the Lead Investigator in the study: "Adrenal hyperplasia among young women with Polycystic Ovarian Syndrome". She submitted the initial protocol 11-CH-0119 and got approval by the Institutional Board Review in January 2011. The main goal is to identify the role of adrenal hyperplasia as a cause of polycystic ovarian syndrome. Moreover, trying to identify possible links between insulin resistance and hyperandrogenism with depression and anxiety. Another aim of the study is to investigate the role of inflammatory markers such as PAI-1, high sensitive CRP with insulin resistance and depression in women with PCOS. Dr Gourgari is also an Associate clinical investigator in the study: "A Clinical and Genetic Investigation of PituitaryTumors and Related Hypothalmic Disorders". Dr Gourgari submitted an amendment to use carotid MRI to screen for early evidence of atherosclerotic plaque in pediatric Cushing syndrome, before and after cure. In addition, she got approval for the use of non-invasive optical imaging to protocol 97CH076 in order to identify an early measurement of cure in patients with Cushing’s after surgery. Dr Gourgari is an Associate investigator in the study “Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients’’: Evaluate and treat pediatric cancer survivor patients for growth failure, primary gonadal failure, primary hypothyroidism, adrenal insufficiency, decreased bone mineral density.Dr Gourgari is an Associate clinical investigator in the study: 95-CH-0059 Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions and an Associate clinical investigator in the study: “Endocrine studies in health and disease”.
Dr. Gourgari also wrote a book chapter for the text “Clinical Genomics: Practical applications in Adult Patient Care.” DrGourgari is a peer reviever in many International journals.
Dr Gourgari is a member of the American Academy of Pediatrics ,The Endocrine Society, The American Association of Clinical Endocrinologists, The Pediatric Endocrine Society , The American Thyroid Association and the Society of Pediatric Research .
Dr. Gourgari has given presentations at national and international conferences such as the 94th Annual Endocrine Society meeting. ENDO, the annual meeting of The Endocrine Society, features more than 200 scientific sessions focused on all areas of endocrinology. Dr Gourgari was invited to give an an oral presentation at ENDO, in which she presented the results of her work on pediatric adrenal Cushing disease. Moreover, Dr Gourgari received three Awards by the Endocrine Society for her work on Polycystic Ovarian Syndrome, which was also presented at The ENDO 2012: The Endocrine Society travel award at ENDO 2012, the Outstanding Abstract Award at ENDO 2012 for the abstract: "A novel method for metabolic classification of polycystic ovarian syndrome" and the Presidential Poster Competition Award at ENDO 2012: “A novel method for metabolic classification of polycystic ovarian syndrome". Dr Gourgari has also received theFellows Intramural Grants Supplement (FIGS) Award by NICHD for submitting a grant proposal to the Office of Dietary Supplements.